0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Prognostic Factors in Cancer (Paperback, illustrated edition) Loot Price: R2,961
Discovery Miles 29 610
Prognostic Factors in Cancer (Paperback, illustrated edition): Paul Hermanek, Mary K. Gospodarowicz, Donald E Henson, Robert...

Prognostic Factors in Cancer (Paperback, illustrated edition)

Paul Hermanek, Mary K. Gospodarowicz, Donald E Henson, Robert V.P. Hutter, Leslie H. Sobin

Series: UICC International Union Against Cancer

 (sign in to rate)
Loot Price R2,961 Discovery Miles 29 610 | Repayment Terms: R277 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients 5]."

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: UICC International Union Against Cancer
Release date: August 1995
First published: 1995
Editors: Paul Hermanek • Mary K. Gospodarowicz • Donald E Henson • Robert V.P. Hutter • Leslie H. Sobin
Dimensions: 235 x 155 x 16mm (L x W x T)
Format: Paperback
Pages: 290
Edition: illustrated edition
ISBN-13: 978-3-540-58688-3
Categories: Books > Medicine > Clinical & internal medicine > Medical diagnosis > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-540-58688-1
Barcode: 9783540586883

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners